Trial · NCT07899203
Effect of Progressive Gamified Motor Rehabilitation After Carpal Tunnel Release
NCT07899203, Not applicable, Not yet recruiting, Al-Zaytoonah University of Jordan
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of Progressive Gamified Motor Rehabilitation After Carpal Tunnel Release. Trials, record NCT07899203. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07899203
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of Progressive Gamified Motor Rehabilitation After Carpal Tunnel Release
- NCT number
- NCT07899203
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 40 participants, estimated
- Lead sponsor
- Al-Zaytoonah University of Jordan
- Conditions
- Carpal Tunnel Surgery
- Interventions
- gamified motor rehabilitation, conventional physical therapy treatment for patient with carpal tunnel syndrome
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Median Nerve Motor Distal Latency and Motor Conduction Velocity | 6 weeks | Median nerve motor distal latency (DL), measured in milliseconds (ms), and motor conduction velocity (MCV), measured in meters per second (m/s), will be assessed using a nerve conduction study before and after the intervention to evaluate motor nerve conduction following carpal tunnel release. |
| Secondary | Arabic Version of the Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH) Questionnaire | 6 weeks | Upper-limb disability and symptoms will be assessed using the Arabic version of the QuickDASH questionnaire, an 11-item patient-reported outcome measure. The total score ranges from 0 to 100, with higher scores indicating greater disability. The questionnaire will be administered at baseline and immediately after the intervention to assess changes in upper-limb functional status. |
| Secondary | Arabic Version of the Boston Carpal Tunnel Questionnaire (BCTQ) Score | 6 weeks | Carpal tunnel syndrome symptoms and functional limitations will be assessed using the Arabic version of the Boston Carpal Tunnel Questionnaire (BCTQ), a patient-reported outcome measure consisting of two subscales: the Symptom Severity Scale (SSS; 11 items) and the Functional Status Scale (FSS; 8 items). Each item is scored on a 1-5 scale, with higher scores indicating greater symptom severity and functional limitation. The questionnaire will be administered at baseline and immediately after the intervention. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07899203
GET https://conductscience.org/api/trials/v1/NCT07899203/registered